- Conditions
- Posttraumatic Stress Disorder, Major Depressive Disorder
- Interventions
- LDAEP, Placebo, sertraline
- Diagnostic Test · Drug
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts • Charleston, South Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1201–1224
of 33,035
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Focal Epilepsy
- Interventions
- ENX-101
- Drug
- Lead sponsor
- Engrail Therapeutics INC
- Industry
- Eligibility
- 18 Years to 75 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 38
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Downey, California + 31 more
- Conditions
- Cognitive Impairments, Schizotypal Personality Disorder
- Interventions
- DAR-0100A, Placebo
- Drug
- Lead sponsor
- Larry J. Siever
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Focal Epilepsy
- Interventions
- BHV-7000, Placebo
- Drug
- Lead sponsor
- Biohaven Therapeutics Ltd.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 390 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 50
- States / cities
- Peoria, Arizona • Phoenix, Arizona • Little Rock, Arkansas + 41 more
- Conditions
- Osteopenia, Osteoporosis
- Interventions
- alendronate sodium, placebo comparator
- Drug · Other
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 45 Years to 65 Years · Female only
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Coccidioidomycosis
- Interventions
- nikkomycin Z, Placebo
- Drug
- Lead sponsor
- University of Arizona
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Tucson, Arizona
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Rimonabant, Placebo (for Rimonabant), Metformin
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 403 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Covid19
- Interventions
- Favipiravir, Placebo
- Drug
- Lead sponsor
- Appili Therapeutics Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,187 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 25
- States / cities
- Pelham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 14 more
- Conditions
- Allergic Conjunctivitis
- Interventions
- Prednisolone Sodium Phosphate Ophthalmic Solution 1%, Tears Naturale II Ophthalmic Solution
- Drug
- Lead sponsor
- ORA, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Dapagliflozin 10mg then Placebo Oral Tablet, Placebo Oral Tablet then Dapagliflozin 10mg
- Drug
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Upper Respiratory Infection
- Interventions
- Montelukast, Placebo
- Drug
- Lead sponsor
- Deborah Gentile
- Other
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2007
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Primary Insomnia, Secondary Insomnia
- Interventions
- LY2624803, Placebo, zolpidem
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 643 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 49
- States / cities
- Birmingham, Alabama • Glendale, Arizona • Mesa, Arizona + 46 more
- Conditions
- Hyponatremia
- Interventions
- YM087
- Drug
- Lead sponsor
- Cumberland Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2003
- U.S. locations
- 27
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Tuscon, Arizona + 24 more
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- MEDI4736, Placebo
- Drug
- Lead sponsor
- Canadian Cancer Trials Group
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 1,415 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2026
- U.S. locations
- 9
- States / cities
- Gilbert, Arizona • Los Angeles, California • Denver, Colorado + 6 more
- Conditions
- Cognitive Impairment
- Interventions
- Dose Escalation of VU319, Dose Escalation of Placebo
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- 18 Years to 55 Years
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Hypertension
- Interventions
- ADX415, Placebo
- Drug
- Lead sponsor
- Addrenex Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 3
- States / cities
- Austin, Texas • San Antonio, Texas
- Conditions
- Neuropathic Pain
- Interventions
- NIN, Sham CES, CES
- Device
- Lead sponsor
- Brooke Army Medical Center
- Federal
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Fort Sam Houston, Texas
- Conditions
- Herpes Zoster, Herpes Zoster Vaccine
- Interventions
- Herpes Zoster Vaccine GSK1437173A, Placebo
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 70 Years and older
- Enrollment
- 14,819 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2015
- U.S. locations
- 43
- States / cities
- Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 36 more
- Conditions
- Overweight, Diabetes, PreDiabetes, Obesity
- Interventions
- Gelesis200, Placebo
- Device
- Lead sponsor
- Gelesis, Inc.
- Industry
- Eligibility
- 22 Years to 65 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 12
- States / cities
- Birmingham, Alabama • Bradenton, Florida • Miami, Florida + 9 more
- Conditions
- Radiation-Induced Xerostomia and Hyposalivation
- Interventions
- RXRG001, Placebo
- Biological
- Lead sponsor
- RiboX Therapeutics Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 5
- States / cities
- Palo Alto, California • Iowa City, Iowa • Baltimore, Maryland + 2 more
- Conditions
- Methamphetamine Use Disorder
- Interventions
- Placebo, Methamphetamine
- Drug
- Lead sponsor
- William Stoops
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Secondary Hyperoxaluria, Nephrolithiasis, Kidney Stones, Hyperoxaluria, Dietary Hyperoxaluria
- Interventions
- ALLN-177 low dose, ALLN-177 mid dose, ALLN-177 high dose, Placebo
- Drug
- Lead sponsor
- Allena Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 16
- States / cities
- Los Angeles, California • Daytona Beach, Florida • Jacksonville, Florida + 13 more
- Conditions
- Diabetes Mellitus, Hypoglycemia, Autonomic Failure
- Interventions
- naloxone, fructose, exercise, Morphine sulfate, Epinephrine
- Drug · Dietary Supplement · Behavioral
- Lead sponsor
- Albert Einstein College of Medicine
- Other
- Eligibility
- 21 Years to 60 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2018
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Attention Deficit Disorder With Hyperactivity, Amphetamine-Related Disorders, Substance-Related Disorders
- Interventions
- NRP104
- Drug
- Lead sponsor
- New River Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland